Finance

Lists
300791:SHE
Sirio Pharma Co Ltd
CNÂ¥17.86
+0.06%
(+0.010) 1D
Oct 16, 3:04:40 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300791...
Open
CNÂ¥17.97
High
CNÂ¥18.28
Low
CNÂ¥17.56
Mkt. cap
5.63B
Avg. vol.
1.68M
Volume
1.20M
Dividend
0.73%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 5, 2026
P/E ratio
41.27
52-wk high
CNÂ¥26.17
52-wk low
CNÂ¥15.40
EPS
CNÂ¥0.43
Shares outstanding
308.23M
No. of employees
3K
Open
CNÂ¥17.97
High
CNÂ¥18.28
Low
CNÂ¥17.56
Mkt. cap
5.63B
Avg. vol.
1.68M
Volume
1.20M
Dividend
0.73%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 5, 2026
P/E ratio
41.27
52-wk high
CNÂ¥26.17
52-wk low
CNÂ¥15.40
EPS
CNÂ¥0.43
Shares outstanding
308.23M
No. of employees
3K
News stories
From web sources and news partners
About Sirio Pharma Co Ltd
CEO-
Employees2.78K
FoundedAug 16, 1993
Headquarters-
SectorPersonal care products
Websitesiriopharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.25B
971.73M
1.00B
1.05B
Cost of goods sold
861.97M
813.57M
678.46M
671.75M
Cost of revenue
861.97M
813.57M
678.46M
671.75M
Research and development expenses
38.35M
45.42M
30.12M
34.04M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
215.84M
212.36M
194.40M
200.73M
Operating expense
257.90M
268.79M
231.64M
249.70M
Total operating expenses
1.12B
1.08B
910.10M
921.45M
Operating income
129.68M
-110.63M
93.23M
127.36M
Other non operating income
-411.82K
3.74M
-19.46M
18.64M
EBT including unusual items
106.40M
-260.84M
51.78M
114.28M
EBT excluding unusual items
98.89M
-137.27M
56.01M
91.01M
Income tax expense
20.83M
-59.41M
9.86M
13.79M
Effective tax rate
19.58%
22.78%
19.03%
12.07%
Other operating expenses
893.72K
9.89M
3.95M
8.62M
Net income
99.15M
-123.74M
49.91M
103.02M
Net profit margin
7.93%
-12.73%
4.97%
9.82%
Earnings per share
-
-
-
-
Interest and investment income
1.48M
3.03M
1.40M
2.80M
Interest expense
-26.72M
-27.07M
-19.16M
-33.79M
Net interest expenses
-25.23M
-24.04M
-17.76M
-30.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
175.38M
-62.67M
-
178.95M
Gain or loss from assets sale
-218.73K
-2.43M
-
-16.53M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps